Original Article

Aspergillosis in Liver Transplant Recipients Successful Treatment and Improved Survival Using a Multistep Approach

Authors: ANDREA DUCHINI MD, DAVID C. REDFIELD MD, JOHN G. McHUTCHISON MD, MATHEW E. BRUNSON MD, PAUL J. POCKROS MD

Abstract

Background. Invasive aspergillosis is a life‐threatening complication in liver transplant recipients, with a reported mortality rate of more than 90%. Treatment is difficult, and no single agent is uniformly effective in treating this patient population.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References